Mimura, S.; Morishita, A.; Oura, K.; Yano, R.; Nakahara, M.; Tadokoro, T.; Fujita, K.; Tani, J.; Tatsuta, M.; Himoto, T.;
et al. Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets. J. Clin. Med. 2025, 14, 8503.
https://doi.org/10.3390/jcm14238503
AMA Style
Mimura S, Morishita A, Oura K, Yano R, Nakahara M, Tadokoro T, Fujita K, Tani J, Tatsuta M, Himoto T,
et al. Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets. Journal of Clinical Medicine. 2025; 14(23):8503.
https://doi.org/10.3390/jcm14238503
Chicago/Turabian Style
Mimura, Shima, Asahiro Morishita, Kyoko Oura, Rie Yano, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Miwa Tatsuta, Takashi Himoto,
and et al. 2025. "Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets" Journal of Clinical Medicine 14, no. 23: 8503.
https://doi.org/10.3390/jcm14238503
APA Style
Mimura, S., Morishita, A., Oura, K., Yano, R., Nakahara, M., Tadokoro, T., Fujita, K., Tani, J., Tatsuta, M., Himoto, T., & Kobara, H.
(2025). Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets. Journal of Clinical Medicine, 14(23), 8503.
https://doi.org/10.3390/jcm14238503